Mobile version of Hanspub

文章引用说明 更多>> (返回到该文章)

R. S. Herbst, D. Prager, R. Hermann, et al. TRIBUTE: A phase III trial of erlotinib (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small cell lung cancer. Journal of Clinical Oncology, 2005, 23(25): 5892-5899.

被以下文章引用: